IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1598 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded77    
    Comments [Add]    

Recommend this journal


Year : 1975  |  Volume : 7  |  Issue : 4  |  Page : 27-30

A double blind clinical study of prenylamine lactate in the cases of ischaemic heart disease

Correspondence Address:
K C Kotia

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

In the present double-blind trial, 25 cares received prenylamine and 26 cases placebo. The patients were observed for 6 weeks before institution of therapy and for another 6 weeks during therapy. Clinical as well as electrocardiographic assessment was done. There was improvement in frequency and severity of anginal attacks and the consumption of GTN tablets in both groups decreased. But this improvement was highly significant in prenylamine serieses compared to placebo. Electrocardiographic improvement was also more marked with prenylamine than with placebo. The side effects were even less marked in prenylamine series. Hence it is concluded that patients of angina pectoris are more benefitted with prenylamine than with placebo.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow